Search

Your search keyword '"Yang, Tsung-Ming"' showing total 169 results
Start Over Author "Yang, Tsung-Ming"
169 results on '"Yang, Tsung-Ming"'

1. Benefit of dual bronchodilator therapy on exacerbations in former and current smokers with chronic obstructive pulmonary disease in real-world clinical practice: a multicenter validation study (TOReTO)

Author

Lai, Yu-Ting, Tsai, Ying-Huang, Hsieh, Meng-Jer, Chen, Ning-Hung, Cheng, Shih-Lung, Tao, Chi-Wei, Wei, Yu-Feng, Wu, Yao-Kuang, Chan, Ming-Cheng, Liu, Shih-Feng, Hsu, Wu-Huei, Yang, Tsung-Ming, Liu, Ching-Lung, Kuo, Ping-Hung, and Lin, Ming-Shian

Published
2024
Full Text
View/download PDF

3. Correlating Reiff scores with clinical, functional, and prognostic factors: characterizing noncystic fibrosis bronchiectasis severity: validation from a nationwide multicenter study in Taiwan

Author

Cheng, Wen-Chien, Chang, Chia-Ling, Sheu, Chau-Chyun, Wang, Ping-Huai, Hsieh, Meng-heng, Chen, Ming-Tsung, Ou, Wei-Fan, Wei, Yu-Feng, Yang, Tsung-Ming, Lan, Chou-Chin, Wang, Cheng-Yi, Lin, Chih-Bin, Lin, Ming-Shian, Wang, Yao-Tung, Lin, Ching-Hsiung, Liu, Shih-Feng, Cheng, Meng-Hsuan, Chen, Yen-Fu, Peng, Chung-Kan, Chan, Ming-Cheng, Chen, Ching-Yi, Jao, Lun-Yu, Wang, Ya-Hui, Chen, Chi-Jui, Chen, Shih-Pin, Tsai, Yi-Hsuan, Cheng, Shih-Lung, Lin, Horng-Chyuan, Chien, Jung-Yien, Wang, Hao-Chien, and Hsu, Wu-Huei

Published
2024
Full Text
View/download PDF

8. Associations Between Severe Influenza‐Complicated Thromboembolism Events, Intensive Care Unit Stays and Mortality, and Associated Risk Factors: A Retrospective Cohort Study.

Author

Lee, Wei‐Chun, Chang, Che‐Chia, Ho, Meng‐Chin, Lin, Chin‐Kuo, Lin, Chieh‐Mo, Fang, Yu‐Hung, Huang, Shu‐Yi, Lin, Yu‐Ching, Chuang, Min‐Chun, Yang, Tsung‐Ming, Hung, Ming‐Szu, Chou, Yen‐Li, Tsai, Ying‐Huang, and Hsieh, Meng‐Jer

Subjects
VENOUS thrombosis, MORTALITY risk factors, INTENSIVE care units, DISEASE risk factors, LOGISTIC regression analysis
Abstract

The association between influenza infection and thromboembolism (TE) events, including cardiovascular events, cerebrovascular events, pulmonary embolism, and deep vein thrombosis, is supported by compelling evidence. However, there is a disparity in the risk factors that impact the outcomes of severe influenza‐complicated TE in intensive care unit (ICU) patients. The objective of this study was to evaluate the outcomes of severe influenza‐complicated TE in ICU patients and identify any associated risk factors. Methods: A retrospective cohort study was conducted, recruiting consecutive patients with TE events admitted to the ICU between December 2015 through December 2018 at our institution in Taiwan. The study included a group of 108 patients with severe influenza and a control group of 192 patients with severe community‐acquired pneumonia. Associations between complicated TE, length of ICU stay, and 90‐day mortality were evaluated using logistic regression analysis, and risk factors were identified using univariate and multivariate generalized linear regression analyses. Results: TE event prevalence was significantly higher in ICU patients with severe influenza than in ICU patients with severe CAP (21.3% vs. 5.7%, respectively; p < 0.05). Patients with severe influenza who developed TE experienced a significant increase in the ratio of mechanical ventilation use, length of mechanical ventilation use, ICU stay, and 90‐day mortality when compared to patients without TE (all p < 0.05). The comparison of severe CAP patients with and without TE revealed no significant differences (p > 0.05). The development of thromboembolic events in patients with severe influenza or severe noninfluenza CAP is linked to influenza infection and hypertension (p < 0.05). Furthermore, complicated TE and the severity of the APACHE II score are risk factors for 90‐day mortality in ICU patients with severe influenza (p < 0.05). Conclusions: Patients with severe influenza and complicated TE are more likely to have an extended ICU stay and 90‐day mortality than patients with severe CAP. The risk is significantly higher for patients with a higher APACHE II score. The results of this study may aid in defining better strategies for early recognition and prevention of severe influenza‐complicated TE. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Clinical Predictors of Nontuberculous Mycobacteria Lung Disease and Coisolates of Potential Pathogenic Microorganisms in Noncystic Fibrosis Bronchiectasis.

Author

Wang, Ping-Huai, Shu, Chin-Chung, Sheu, Chau-Chyun, Chang, Chia-Ling, Hsieh, Meng-Heng, Hsu, Wu-Huei, Chen, Ming-Tsung, Ou, Wei-Fan, Wei, Yu-Feng, Yang, Tsung-Ming, Lan, Chou-Chin, Wang, Cheng-Yi, Lin, Chih-Bin, Lin, Ming-Shian, Wang, Yao-Tung, Lin, Ching-Hsiung, Liu, Shih-Feng, Cheng, Meng-Hsuan, Chen, Yen-Fu, and Cheng, Wen-Chien

Subjects
CHRONIC obstructive pulmonary disease, BRONCHIECTASIS, COMPUTED tomography, ACINETOBACTER baumannii, PATHOGENIC microorganisms, LUNG diseases
Abstract

Background In bronchiectasis, nontuberculous mycobacteria (NTM) lung disease (NTM-LD) is a well-known coexisting infection. However, microorganism coisolates and clinical NTM-LD predictors are poorly studied. Methods Patients with bronchiectasis diagnosed by means of computed tomography between January 2017 and June 2020 were screened, using the date of computed tomography as the index date. Those with a major bronchiectasis diagnosis in ≥2 follow-up visits after the index date were enrolled in the study, and NTM-LD occurrence and its association with pneumonia and hospitalization within 1 year were analyzed. Results Of the 2717 participants, 79 (2.9%) had NTM-LD diagnosed. The factors associated with NTM-LD included hemoptysis, postinfectious bronchiectasis, a tree-in-bud score ≥2, a modified Reiff score ≥4, and chronic obstructive pulmonary disease (adjusted odds ratios, 1.80, 2.36, 1.78, 2.95, and 0.51, respectively). Compared with patients in the non-NTM group, those with NTM-LD had higher rates of hospitalization (15.9% vs 32.9%; P <.001) and pneumonia (9.8% vs 20.3%; P =.003). Pseudomonas aeruginosa was the most common microorganism in those with NTM-LD and those in the non-NTM group (10.1% vs 7.8%; P =.40). However, compared with those in the non-NTM group, Acinetobacter baumannii and Escherichia coli were more prevalent in patients with NTM-LD (0.7% vs 3.8% [ P =.03%] and 1.0% vs 3.8% [ P =.05], respectively). Conclusions Postinfectious bronchiectasis with hemoptysis, higher radiological involvement, and a tree-in-bud pattern were associated with NTM-LD risk. The rate of A baumannii and E coli coisolation was higher in bronchiectasis populations with NTM-LD. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

11. Author Correction: A highly sensitive and specific real-time quantitative PCR for BRAF V600E/K mutation screening

Author

Lung, Jrhau, Hung, Ming‑Szu, Lin, Yu‑Ching, Jiang, Yuan Yuan, Fang, Yu‑Hung, Lu, Ming‑Shian, Hsieh, Ching‑Chuan, Wang, Chia‑Siu, Kuan, Feng‑Che, Lu, Chang‑Hsien, Chen, Ping‑Tsung, Lin, Chieh‑Mo, Chou, Yen‑Li, Lin, Chin‑Kuo, Yang, Tsung‑Ming, Chen, Fen Fen, Lin, Paul Yann, Hsieh, Meng‑Jer, and Tsai, Ying Huang

Published
2021
Full Text
View/download PDF

12. Associations between severe influenza-complicated thromboembolism events, intensive care unit stays and mortality, and associated risk factors: a retrospective cohort study

Author

LEE, WEI CHUN, primary, Chang, Che-Chia, additional, Ho, Meng-Chin, additional, LIN, Chin-Kuo, additional, Lin, Chieh-Mo, additional, Fang, Yu-Hung, additional, Huang, Shu-Yi, additional, Lin, Yu-Ching, additional, Chuang, Min-Chun, additional, Yang, Tsung-Ming, additional, Hung, Ming-Szu, additional, Chou, Yen-Li, additional, Tsai, Ying-Huang, additional, and Hsieh, Meng-Jer, additional

Published
2023
Full Text
View/download PDF

14. The Intention of Inhaled Medication Adherence Scale (IMAS): The Development of a New Instrument for Assessing Inhaled Medication Adherence Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Using Theory of Planned Behavior

Author

Wang, Yin-Han, primary, Yang, Tsung-Ming, additional, Hung, Ming-Szu, additional, Lin, Yu-Ching, additional, Fang, Tien-Pei, additional, Kuo, Tzu-Tzu, additional, Griffiths, Mark D, additional, and Lin, Chung-Ying, additional

Published
2023
Full Text
View/download PDF

18. The Intention of Inhaled Medication Adherence Scale (IMAS): The Development of a New Instrument for Assessing Inhaled Medication Adherence Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Using Theory of Planned Behavior

Author

Wang,Yin-Han, Yang,Tsung-Ming, Hung,Ming-Szu, Lin,Yu-Ching, Fang,Tien-Pei, Kuo,Tzu-Tzu, Griffiths,Mark D, Lin,Chung-Ying, Wang,Yin-Han, Yang,Tsung-Ming, Hung,Ming-Szu, Lin,Yu-Ching, Fang,Tien-Pei, Kuo,Tzu-Tzu, Griffiths,Mark D, and Lin,Chung-Ying

Abstract

Yin-Han Wang,1 Tsung-Ming Yang,2,3 Ming-Szu Hung,2– 4 Yu-Ching Lin,2– 4 Tien-Pei Fang,1,3 Tzu-Tzu Kuo,5,&ast; Mark D Griffiths,6 Chung-Ying Lin7– 10,&ast; 1Department of Respiratory Therapy, Chang Gung Memorial Hospital, Chiayi, Taiwan; 2Department of Pulmonary and Critical Care Medicine, Chang Gung Memorial Hospital, Chiayi Branch, Chiayi, Taiwan; 3Department of Respiratory Care, Chang Gung University of Science and Technology, Chiayi, Taiwan; 4Department of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan; 5Division of Respiratory Medicine, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung City, Taiwan; 6International Gaming Research Unit, Psychology Department, Nottingham Trent University, Nottingham, UK; 7Institute of Allied Health Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan; 8Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan; 9Biostatistics Consulting Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; 10Department of Occupational Therapy, College of Medicine, National Cheng Kung University, Tainan, Taiwan&ast;These authors contributed equally to this workCorrespondence: Chung-Ying Lin, Institute of Allied Health Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Tel +886-6-2353535 ext. 5106, Fax +886-6-2367981, Email cylin36933@gmail.com Tzu-Tzu Kuo, Division of Respiratory Medicine, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung City, Taiwan, Email ed101231@gmail.comPurpose: Inhaled medication adherence is an important issue for patients with chronic obstructive pulmonary disease (COPD) because adhering to inhaled medications could substantially improve their health. However, patients with COPD may not be always adhere to the prescribed inhaled medications. Therefore, understanding the underly

Published
2023

19. The potential and limitation of targeted chromosomal breakpoint sequencing for the ROS1 fusion gene identification in lung cancer

Author

Hung, Ming-Szu, Lin, Yu-Ching, Chen, Fen-Fen, Jiang, Yuan-Yuan, Fang, Yu-Hung, Lu, Ming-Shian, Lin, Chin-Kuo, Yang, Tsung-Ming, Lung, Jrhau, Chen, Chih-Cheng, Lee, Kuan-Der, and Tsai, Ying-Huang

Subjects
Original Article
Abstract

ROS1 fusion genes are rare but important driver genes in lung cancer. Owing to their rarity, many clinicopathological features and treatment responses for each ROS1 fusion variant are still largely unknown and require further investigation. RNA is the preferable template for the ROS1 fusion gene screening, but deterioration of RNA in FFPE often makes the detection challenging. To resolve the difficulty, a targeted chromosomal breakpoint sequencing method was developed for searching the ROS1 fusion gene, and was compared with fluorescence in situ hybridization, immunohistochemistry, RT-qPCR using 260 lung cancer samples of Southern Taiwan. The results showed that ROS1-altered cases were present at low frequencies, did not share distinct clinicopathological features, and often carried other driver mutations. The performance of the targeted sequencing assay was superior to the RT-qPCR in ROS1 fusion gene identification when the cDNAs were from FFPE samples, but long-read DNA sequencing and fresh-frozen samples would be better to revolve all fusion genes. Precise determination of all ROS1 fusion variants and concomitant driver mutations using both genomic DNA and RNA would be required to help improve the treatment of patients with ROS1 alterations.

Published
2022

21. Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations

Author

Lin, Chieh-Mo, Yang, Tsung-Ming, Yang, Yao-Hsu, Tsai, Ying-Huang, Lee, Chuan-Pin, Chen, Pau-Chung, Chen, Wen-Cheng, and Hsieh, Meng-Jer

Subjects
Adult, Aged, 80 and over, Male, Time Factors, Databases, Factual, Respiratory System Agents, Taiwan, statin, International Journal of Chronic Obstructive Pulmonary Disease, Middle Aged, Prognosis, Risk Assessment, chronic obstructive pulmonary disease, Hospitalization, Pulmonary Disease, Chronic Obstructive, exacerbation, Risk Factors, Disease Progression, Humans, Female, Hydroxymethylglutaryl-CoA Reductase Inhibitors, frequent exacerbator, Aged, Retrospective Studies, Original Research
Abstract

Chieh-Mo Lin, 1, 2 Tsung-Ming Yang, 1 Yao-Hsu Yang, 3–5 Ying-Huang Tsai, 6, 7 Chuan-Pin Lee, 4 Pau-Chung Chen, 8–11 Wen-Cheng Chen, 12 Meng-Jer Hsieh 1, 7 1Department of Pulmonary and Critical Care Medicine, Chiayi Chang Gung Memorial Hospital, Chang Gung Medical Foundation, Chiayi, Taiwan; 2Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan City, Taiwan; 3Department of Traditional Chinese Medicine, Chiayi Chang Gung Memorial Hospital, Chang Gung Medical Foundation, Chiayi, Taiwan; 4Health Information and Epidemiology Laboratory of Chang Gung Memorial Hospital, Chang Gung Medical Foundation, Chiayi, Taiwan; 5School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan; 6Department of Pulmonary and Critical Care Medicine, Linkou Chang Gung Memorial Hospital, Chang Gung Medical Foundation, Taoyuan, Taiwan; 7Department of Respiratory Therapy, School of Medicine, Chang Gung University, Taoyuan, Taiwan; 8Institute of Environmental and Occupational Health Sciences, National Taiwan University College of Public Health, Taipei, Taiwan; 9Department of Public Health, National Taiwan University College of Public Health, Taipei, Taiwan; 10Department of Environmental and Occupational Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; 11Office of Occupational Safety and Health, National Taiwan University Hospital, Taipei, Taiwan; 12Department of Radiation Oncology, Chiayi Chang Gung Memorial Hospital, Chang Gung Medical Foundation, Chiayi, TaiwanCorrespondence: Meng-Jer HsiehDepartment of Pulmonary and Critical Care Medicine, Chiayi Chang Gung Memorial Hospital, Chang Gung Medical Foundation, No. 6, West Sec., Jiapu Road, Puzi City, Chiayi County 61363, TaiwanTel +886-5-3621000Email mengjer@yahoo.comRationale: The potential benefits of statins for the prevention of exacerbations in patients with COPD remains controversial. No previous studies have investigated the impact of statins on clinical outcomes in COPD patients with frequent exacerbations.Objective: This study aimed to evaluate the association between the use of statins and the risk of subsequent hospitalized exacerbations in COPD frequent exacerbators.Materials and Methods: We conducted a population-based cohort study using the Taiwan National Health Insurance Research Database. 139,223 COPD patients with a first hospitalized exacerbation between 2004 and 2012 were analyzed. Among them, 35,482 had a second hospitalized exacerbation within a year after the first exacerbation, and were defined as frequent exacerbators. 1:4 propensity score matching was used to create matched samples of statin users and non-users. The competing risk regression analysis model was used to evaluate the association between statin use and exacerbation risk.Results: The use of statins was associated with a significantly reduced risk in subsequent hospitalized exacerbations in COPD patients after their first hospitalized exacerbation (adjusted subdistribution hazard ration [SHR], 0.89; 95% CI, 0.85– 0.93, P< 0.001). In frequent exacerbators, the SHR for subsequent hospitalized exacerbations in statins users was 0.88 (95% CI, 0.81– 0.94, P=0.001). Subgroup analysis among frequent exacerbators demonstrated that the use of statins only provided a protective effect against subsequent hospitalized exacerbations in male patients aged 75 years and older, with coexisting diabetes mellitus, hypertension or cardiovascular disease, and no protective effect was observed in those with lung cancer or depression. Current use of statins was associated with a greater protective effect for reducing subsequent hospitalized exacerbation.Conclusion: The use of statins was associated with a significant reduction in the risk of hospitalized exacerbations in COPD patients after a first hospitalized exacerbation and in specified COPD frequent exacerbators.Keywords: chronic obstructive pulmonary disease, statin, exacerbation, frequent exacerbator

Published
2020

22. Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study

Author

Hsieh,Meng-Jer, Chen,Ning-Hung, Cheng,Shih-Lung, Tao,Chi-Wei, Wei,Yu-Feng, Wu,Yao-Kuang, Chan,Ming-Cheng, Liu,Shih-Feng, Hsu,Wu-Huei, Yang,Tsung-Ming, Lin,Ming-Shian, Liu,Ching-Lung, Kuo,Ping-Hung, Tsai,Ying-Huang, Hsieh,Meng-Jer, Chen,Ning-Hung, Cheng,Shih-Lung, Tao,Chi-Wei, Wei,Yu-Feng, Wu,Yao-Kuang, Chan,Ming-Cheng, Liu,Shih-Feng, Hsu,Wu-Huei, Yang,Tsung-Ming, Lin,Ming-Shian, Liu,Ching-Lung, Kuo,Ping-Hung, and Tsai,Ying-Huang

Abstract

Meng-Jer Hsieh,1 Ning-Hung Chen,2 Shih-Lung Cheng,3,4 Chi-Wei Tao,5 Yu-Feng Wei,6,7 Yao-Kuang Wu,8 Ming-Cheng Chan,9,10 Shih-Feng Liu,11– 13 Wu-Huei Hsu,14 Tsung-Ming Yang,15 Ming-Shian Lin,16,17 Ching-Lung Liu,18 Ping-Hung Kuo,19 Ying-Huang Tsai1,20 1Department of Pulmonary and Critical Care Medicine, Linkou Chang Gung Memorial Hospital, Chang Gung Medical Foundation and Department of Respiratory Therapy, College of Medicine, Chang Gung University, Taoyuan, Taiwan; 2Department of Pulmonary and Critical Care Medicine, Linkou Chang Gung Memorial Hospital and School of Traditional Chinese Medicine, Chang Gung University, Taoyuan, Taiwan; 3Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei, Taiwan; 4Department of Chemical Engineering and Materials Science, Yuan Ze University, Zhongli, Taoyuan, Taiwan; 5Department of Internal Medicine, Cheng-Hsin General Hospital, Taipei, Taiwan; 6School of Medicine for International Students, College of Medicine, I-Shou University, Kaohsiung, Taiwan; 7Department of Internal Medicine, E-Da Cancer Hospital, Kaohsiung, Taiwan; 8Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan; 9Division of Critical Care and Respiratory Therapy, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; 10National Chung Hsing University, Taichung, Taiwan; 11Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; 12Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan; 13College of Medicine, Chang Gung University, Taoyuan, Taiwan; 14Critical Medical Center, China Medical University Hospital, Taichung, Taiwan; 15Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan; 16Division of Pulmonary Medicine, Departm

Published
2022

23. Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study

Author

Hsieh, Meng-Jer, primary, Chen, Ning-Hung, additional, Cheng, Shih-Lung, additional, Tao, Chi-Wei, additional, Wei, Yu-Feng, additional, Wu, Yao-Kuang, additional, Chan, Ming-Cheng, additional, Liu, Shih-Feng, additional, Hsu, Wu-Huei, additional, Yang, Tsung-Ming, additional, Lin, Ming-Shian, additional, Liu, Ching-Lung, additional, Kuo, Ping-Hung, additional, and Tsai, Ying-Huang, additional

Published
2022
Full Text
View/download PDF

25. Performance and Clinical Utility of Various Chronic Obstructive Pulmonary Disease Case-Finding Tools

Author

Chen, Chiung-Zuei, primary, Sheu, Chau-Chyun, additional, Cheng, Shih-Lung, additional, Wang, Hao-Chien, additional, Lin, Meng-Chih, additional, Hsu, Wu-Huei, additional, Lee, Kang-Yun, additional, Perng, Diahn-Warng, additional, Lin, Hen-I, additional, Lin, Ming-Shian, additional, Lin, Sheng-Hao, additional, Tsai, Jong-Rung, additional, Wang, Chin-Chou, additional, Wang, Cheng-Yi, additional, Yang, Tsung-Ming, additional, Liu, Ching-Lung, additional, Wang, Tsai-Yu, additional, and Lin, Ching-Hsiung, additional

Published
2021
Full Text
View/download PDF

27. Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan

Author

Cheng, Shih-Lung, primary, Li, Yi-Rong, additional, Huang, Nicole, additional, Yu, Chong-Jen, additional, Wang, Hao-Chien, additional, Lin, Meng-Chih, additional, Chiu, Kuo-Chin, additional, Hsu, Wu-Huei, additional, Chen, Chiung-Zuei, additional, Sheu, Chau-Chyun, additional, Perng, Diahn-Warng, additional, Lin, Sheng-Hao, additional, Yang, Tsung-Ming, additional, Lin, Chih-Bin, additional, Kor, Chew-Teng, additional, and Lin, Ching-Hsiung, additional

Published
2021
Full Text
View/download PDF

32. The Prevalence and the Impacts of Pulmonary Bacterial Coinfections and Secondary Bacterial Pneumonia in Patients with Severe Influenza Pneumonitis

Author

Lee, Wei-Chun, primary, Ho, Meng-Chin, additional, Chang, Che-Chia, additional, Lin, Chieh-Mo, additional, Leu, Shaw-Woei, additional, Lin, Chin-Kuo, additional, Lin, Yu-Chin, additional, Fang, Yu-Hung, additional, Huang, Shu-Yi, additional, Yang, Tsung-Ming, additional, Tsai, Ying-Huang, additional, and Hsieh, Meng-Jer, additional

Published
2021
Full Text
View/download PDF

34. Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan

Author

Cheng,Shih-Lung, Li,Yi-Rong, Huang,Nicole, Yu,Chong-Jen, Wang,Hao-Chien, Lin,Meng-Chih, Chiu,Kuo-Chin, Hsu,Wu-Huei, Chen,Chiung-Zuei, Sheu,Chau-Chyun, Perng,Diahn-Warng, Lin,Sheng-Hao, Yang,Tsung-Ming, Lin,Chih-Bin, Kor,Chew-Teng, Lin,Ching-Hsiung, Cheng,Shih-Lung, Li,Yi-Rong, Huang,Nicole, Yu,Chong-Jen, Wang,Hao-Chien, Lin,Meng-Chih, Chiu,Kuo-Chin, Hsu,Wu-Huei, Chen,Chiung-Zuei, Sheu,Chau-Chyun, Perng,Diahn-Warng, Lin,Sheng-Hao, Yang,Tsung-Ming, Lin,Chih-Bin, Kor,Chew-Teng, and Lin,Ching-Hsiung

Abstract

Shih-Lung Cheng,1,2,&ast; Yi-Rong Li,3,&ast; Nicole Huang,4 Chong-Jen Yu,5 Hao-Chien Wang,5 Meng-Chih Lin,6 Kuo-Chin Chiu,7 Wu-Huei Hsu,8 Chiung-Zuei Chen,9 Chau-Chyun Sheu,10,11 Diahn-Warng Perng,12 Sheng-Hao Lin,13 Tsung-Ming Yang,14 Chih-Bin Lin,15 Chew-Teng Kor,16 Ching-Hsiung Lin13,17,18 1Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei, 220, Taiwan; 2Department of Chemical Engineering and Materials Science, Yuan Ze University, Zhongli, Taoyuan, 320, Taiwan; 3Changhua Christian Hospital, Thoracic Medicine Research Center, Changhua, 500, Taiwan; 4Institute of Hospital and Health Care Administration, National Yang Ming Chiao Tung University, Taipei, 112, Taiwan; 5Department of Internal Medicine, National Taiwan University Hospital, Taipei, 100, Taiwan; 6Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, 833, Taiwan; 7Division of Chest, Department of Internal Medicine, Poh-Ai Hospital, Luodong, 265, Taiwan; 8Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, 404, Taiwan; 9Division of Pulmonary Medicine, Department of Internal Medicine, National Cheng Kung University, College of Medicine and Hospital, Tainan, 701, Taiwan; 10Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, 807, Taiwan; 11Department of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, 807, Taiwan; 12Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, 112, Taiwan; 13Department of Internal Medicine, Division of Chest Medicine, Changhua Christian Hospital, Changhua, 500, Taiwan; 14Department of Pulmonary and Critical Care Medicine, Chang Gung Memorial Hospital, Chiayi Branch, 613, Taiwan; 15Department of Internal Medicine

Published
2021

35. Performance and Clinical Utility of Various Chronic Obstructive Pulmonary Disease Case-Finding Tools

Author

Chen,Chiung-Zuei, Sheu,Chau-Chyun, Cheng,Shih-Lung, Wang,Hao-Chien, Lin,Meng-Chih, Hsu,Wu-Huei, Lee,Kang-Yun, Perng,Diahn-Warng, Lin,Hen-I, Lin,Ming-Shian, Lin,Sheng-Hao, Tsai,Jong-Rung, Wang,Chin-Chou, Wang,Cheng-Yi, Yang,Tsung-Ming, Liu,Ching-Lung, Wang,Tsai-Yu, Lin,Ching-Hsiung, Chen,Chiung-Zuei, Sheu,Chau-Chyun, Cheng,Shih-Lung, Wang,Hao-Chien, Lin,Meng-Chih, Hsu,Wu-Huei, Lee,Kang-Yun, Perng,Diahn-Warng, Lin,Hen-I, Lin,Ming-Shian, Lin,Sheng-Hao, Tsai,Jong-Rung, Wang,Chin-Chou, Wang,Cheng-Yi, Yang,Tsung-Ming, Liu,Ching-Lung, Wang,Tsai-Yu, and Lin,Ching-Hsiung

Abstract

Chiung-Zuei Chen,1 Chau-Chyun Sheu,2 Shih-Lung Cheng,3,4 Hao-Chien Wang,5 Meng-Chih Lin,6 Wu-Huei Hsu,7 Kang-Yun Lee,8 Diahn-Warng Perng,9 Hen-I Lin,10 Ming-Shian Lin,11 Sheng-Hao Lin,12 Jong-Rung Tsai,13 Chin-Chou Wang,6 Cheng-Yi Wang,10 Tsung-Ming Yang,14 Ching-Lung Liu,15 Tsai-Yu Wang,16 Ching-Hsiung Lin12,17,18 1Division of Pulmonary Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; 2Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, 807, Taiwan; 3Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei, 220, Taiwan; 4Department of Chemical Engineering and Materials Science, Yuan Ze University, Zhongli, Taoyuan, 320, Taiwan; 5Department of Internal Medicine, National Taiwan University Hospital, Taipei, 100, Taiwan; 6Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, 404, Taiwan; 7Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, 833, Taiwan; 8Division of Pulmonary Medicine, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, 110, Taiwan; 9Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, 112, Taiwan; 10Department of Internal Medicine, Cardinal Tien Hospital, Fu-Jen Catholic University, Taipei, 242, Taiwan; 11Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, 600, Taiwan; 12Division of Chest Medicine, Changhua Christian Hospital, Changhua, 500, Taiwan; 13Division of Respiratory Therapy, College of Medicine, Kaohsiung Medical University, Kaohsiung, 807, Taiwan; 14Department of Pulmonary and Critical Care Medicine, Chang Gung Memorial Hospital, Taoyuan City

Published
2021

37. Novel App-Based Portable Spirometer for the Early Detection of COPD

Author

Lin, Ching-Hsiung, primary, Cheng, Shih-Lung, additional, Wang, Hao-Chien, additional, Hsu, Wu-Huei, additional, Lee, Kang-Yun, additional, Perng, Diahn-Warng, additional, Lin, Hen-I., additional, Lin, Ming-Shian, additional, Tsai, Jong-Rung, additional, Wang, Chin-Chou, additional, Lin, Sheng-Hao, additional, Wang, Cheng-Yi, additional, Chen, Chiung-Zuei, additional, Yang, Tsung-Ming, additional, Liu, Ching-Lung, additional, Wang, Tsai-Yu, additional, and Lin, Meng-Chih, additional

Published
2021
Full Text
View/download PDF

42. Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations

Author

Lin,Chieh-Mo, Yang,Tsung-Ming, Yang,Yao-Hsu, Tsai,Ying-Huang, Lee,Chuan-Pin, Chen,Pau-Chung, Chen,Wen-Cheng, Hsieh,Meng-Jer, Lin,Chieh-Mo, Yang,Tsung-Ming, Yang,Yao-Hsu, Tsai,Ying-Huang, Lee,Chuan-Pin, Chen,Pau-Chung, Chen,Wen-Cheng, and Hsieh,Meng-Jer

Abstract

Chieh-Mo Lin, 1, 2 Tsung-Ming Yang, 1 Yao-Hsu Yang, 3–5 Ying-Huang Tsai, 6, 7 Chuan-Pin Lee, 4 Pau-Chung Chen, 8–11 Wen-Cheng Chen, 12 Meng-Jer Hsieh 1, 7 1Department of Pulmonary and Critical Care Medicine, Chiayi Chang Gung Memorial Hospital, Chang Gung Medical Foundation, Chiayi, Taiwan; 2Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan City, Taiwan; 3Department of Traditional Chinese Medicine, Chiayi Chang Gung Memorial Hospital, Chang Gung Medical Foundation, Chiayi, Taiwan; 4Health Information and Epidemiology Laboratory of Chang Gung Memorial Hospital, Chang Gung Medical Foundation, Chiayi, Taiwan; 5School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan; 6Department of Pulmonary and Critical Care Medicine, Linkou Chang Gung Memorial Hospital, Chang Gung Medical Foundation, Taoyuan, Taiwan; 7Department of Respiratory Therapy, School of Medicine, Chang Gung University, Taoyuan, Taiwan; 8Institute of Environmental and Occupational Health Sciences, National Taiwan University College of Public Health, Taipei, Taiwan; 9Department of Public Health, National Taiwan University College of Public Health, Taipei, Taiwan; 10Department of Environmental and Occupational Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; 11Office of Occupational Safety and Health, National Taiwan University Hospital, Taipei, Taiwan; 12Department of Radiation Oncology, Chiayi Chang Gung Memorial Hospital, Chang Gung Medical Foundation, Chiayi, TaiwanCorrespondence: Meng-Jer HsiehDepartment of Pulmonary and Critical Care Medicine, Chiayi Chang Gung Memorial Hospital, Chang Gung Medical Foundation, No. 6, West Sec., Jiapu Road, Puzi City, Chiayi County 61363, TaiwanTel +886-5-3621000Email mengjer@yahoo.comRationale: The potential benefits of statins for the prevention of exacerbations in patients with COPD remains con

Published
2020

43. MET exon 14 skipping mutations and gene amplification in a Taiwanese lung cancer population

Author

Lung, Jrhau, primary, Hung, Ming-Szu, additional, Lin, Yu-Ching, additional, Lee, Kam-Fai, additional, Jiang, Yuan Yuan, additional, Huang, Shao-Lan, additional, Fang, Yu-Hung, additional, Lu, Ming-Shian, additional, Lin, Chin-Kuo, additional, Yang, Tsung-Ming, additional, Lin, Paul Yann, additional, Hsieh, Meng-Jer, additional, and Tsai, Ying Huang, additional

Published
2019
Full Text
View/download PDF

44. A laser noise reduction method for holographic pickup heads

Author

Freeman, Mark O., Shih, Hsi-Fu, Yang, Tzu-Ping, Wang, Jin-Kang, Yang, Tsung-Ming, Lei, Kuo-Lung, Chuang, Yuh-Horng, and Chang, Ming-Wen

Subjects
Laser recording -- Research, Electromagnetic noise -- Research, Holography -- Research, Business, Electronics, Electronics and electrical industries
Abstract

There are several methods to avoid optical feedback and reduce laser noise in optical recording systems. However, most of them utilize high cost optical components or electronics or increase the pickup head size. Furthermore, it is difficult to fit these components into in a small package like a holographic laser module. In this paper, a simple method for avoiding feedback noise in a holographic pickup head is proposed. A single wave plate is added to the optical system to rotate the polarization of the laser feedback to be orthogonal to the emitting polarization state. Experimental results show that it is feasible and practically reduces laser noise.

Published
1998

45. A novel dual focus objective lens for DVD/CD pick-up head

Author

Liu, Pei-Yih, Shieh, Han-Ping D., Ju, Jau-Jiu, Tsai, Shin-Ter, Yang, Tsung-Ming, Chang, Tsung-Kai, and Liu, Jiin-Song

Subjects
Digital video disk -- Research, Compact discs -- Research, Magnetic lenses -- Research, Business, Electronics, Electronics and electrical industries
Abstract

A new dual focus objective lens of combining aspherical surfaces of DVD and CD for DVD/CD pick-up head was designed. Numerical analysis based on the diffraction model were studied to trade off the spot size, side lobe, and energy ratio of DVD and CD. The hybrid aspherical surfaces of DVD and CD are optimized for low aberration. The spot size of full wave half maximum (FWHM) are 0.553 and 0.88 [[micro]meter] for DVD and CD, respectively, measured from thus constructed double rings lens.

Published
1998

47. The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study

Author

Hsieh, Meng-Jer, primary, Huang, Shu-Yi, additional, Yang, Tsung-Ming, additional, Tao, Chi-Wei, additional, Cheng, Shih-Lung, additional, Lee, Chao-Hsien, additional, Kuo, Ping-Hung, additional, Wu, Yao-Kuang, additional, Chen, Ning-Hung, additional, Hsu, Wu-Huei, additional, Hsu, Jeng-Yuan, additional, Lin, Ming-Shaun, additional, Wang, Chin-Chou, additional, Wei, Yu-Feng, additional, and Tsai, Ying-Huang, additional

Published
2018
Full Text
View/download PDF

48. The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study

Author

Hsieh,Meng-Jer, Huang,Shu-Yi, Yang,Tsung-Ming, Tao,Chi-Wei, Cheng,Shih-Lung, Lee,Chao-Hsien, Kuo,Ping-Hung, Wu,Yao-Kuang, Chen,Ning-Hung, Hsu,Wu-Huei, Hsu,Jeng-Yuan, Lin,Ming-Shaun, Wang,Chin-Chou, Wei,Yu-Feng, Tsai,Ying-Huang, Hsieh,Meng-Jer, Huang,Shu-Yi, Yang,Tsung-Ming, Tao,Chi-Wei, Cheng,Shih-Lung, Lee,Chao-Hsien, Kuo,Ping-Hung, Wu,Yao-Kuang, Chen,Ning-Hung, Hsu,Wu-Huei, Hsu,Jeng-Yuan, Lin,Ming-Shaun, Wang,Chin-Chou, Wei,Yu-Feng, and Tsai,Ying-Huang

Abstract

Meng-Jer Hsieh,1,2 Shu-Yi Huang,1 Tsung-Ming Yang,1 Chi-Wei Tao,3 Shih-Lung Cheng,4 Chao-Hsien Lee,5 Ping-Hung Kuo,6 Yao-Kuang Wu,7,8 Ning-Hung Chen,9 Wu-Huei Hsu,10 Jeng-Yuan Hsu,11 Ming-Shian Lin,12 Chin-Chou Wang,13 Yu-Feng Wei,14 Ying-Huang Tsai1,2 1Department of Pulmonary and Critical Care Medicine, Chiayi Chang Gung Memorial Hospital, Chang-Gung Medical foundation, Chiayi, Taiwan; 2Department of Respiratory Therapy, School of Medicine, Chang-Gung University, Taoyuan, Taiwan; 3Department of Internal Medicine, Cheng Hsin General Hospital, Taipei, Taiwan; 4Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei; 5Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan; 6Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; 7Division of Pulmonary Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan; 8School of Medicine, Tzu Chi University, Hualien, Taiwan; 9Department of pulmonary and critical care medicine, LinKou Chang Gung Memorial Hospital, Taoyuan, Taiwan; 10Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan; 11Division of Chest Medicine, Taichung Veterans General Hospital, Taiwan; 12Dpartment of Internal Medicine, Ditmanson Medical Foundation, Chia-Yi Cristian Hospital, Chia-Yi, Taiwan; 13Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang-Gung Medical Foundation, Kaohsiung, Taiwan; 14Department of Internal Medicine E-Da Hospital, I-Shou University, Kaohsiung, Taiwan Background: This nationwide study was performed to evaluate the evolution of distributions of patients with COPD according to the 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines and to assess the concordance between the prescribed medicati

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results